Protein Kinase C Inhibitors in the Treatment of Diabetic Retinopathy. Review

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|12|3|386-391

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.12, Iss.3, 2011-01, pp. : 386-391

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral Targeting of Protein Kinase C Receptor: Promising Route for Diabetic Retinopathy?

By  

Current Drug Delivery, Vol. 9, Iss. 4, 2012-07 ,pp. : 405-413

Bentham Science Publishers

Access to resources Recommend Favorite

The protein kinase C-β inhibitor, ruboxistaurin, for the treatment of diabetic microvascular complications

By Vinik Aaron  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 12, 2005-12 ,pp. : 1547-1559

Informa Healthcare

Access to resources Recommend Favorite

Protein Kinase C Inhibitors: Rationale for Use and Potential in the Treatment of Bipolar Disorder

By Zarate Carlos A.   Manji Husseini K.  

CNS Drugs, Vol. 23, Iss. 7, 2009-07 ,pp. : 569-582

Adis International

Access to resources Recommend Favorite

Protein kinase C inhibitors: a patent review (2010 – present)

By Sobhia Masilamani Elizabeth   Grewal Baljinder K   Paul Matam Losery Stanly   Patel Jigneshkumar   Kaur Amandeep   Haokip Thongtinlal   Kokkula Alekhya  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 11, 2013-11 ,pp. : 1451-1468

Informa Healthcare

Access to resources Recommend Favorite

Protein kinase C inhibitors: a patent review (2008 – 2009)

By Sobhia M Elizabeth   Grewal Baljinder K   ML Stanly Paul   Patel Jigneshkumar   Kaur Amandeep   Haokip Thongtinlal   Kokkula Alekhya  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 10, 2013-10 ,pp. : 1297-1315

Informa Healthcare

Access to resources Recommend Favorite